Angstrom6

About the Target

Angstrom6 (A6 Peptide) is a capped, eight l-amino acid peptide (Ac-KPSSPPEE-NH2) derived from the biologically active connecting peptide domain of the serine protease, human urokinase plasminogen activator (uPA), which can binds to CD44 resulting in the inhibition of migration, invasion, and metastasis. The mapped target for this entry is CD44 antigen (CD44). In research settings, this mapped target is typically treated as a catalytic or regulatory node whose activity can alter substrate turnover, pathway flux, and stress responses over relatively short experimental time scales. In workflow-oriented studies, investigators often focus on sample quality, assay background, and biochemical workflow performance. This framing is particularly useful in experiments that connect controlled target modulation with rapid changes in catalytic or pathway readouts.

Research Context

Because it combines binding with signaling modulation, the peptide is best interpreted with assays that track both occupancy-related and downstream functional responses. In practice, dose-response design, timing, and matched control conditions are important for separating direct target engagement from delayed compensatory responses. The available sequence cue can also be useful for tracking construct identity across screening and follow-up experiments.

• link phenotypic changes to catalytic or substrate-based biomarkers rather than relying on a single endpoint
• use timed addition or washout designs when direct and downstream effects need to be separated
• benchmark interpretation with orthogonal pathway controls or reference inhibitors where appropriate

Experimental interpretation should therefore connect early pathway changes with later phenotypic outputs, rather than relying on a single endpoint in isolation.

Format Considerations

For routine mechanistic work, the unmodified catalog format provides a consistent starting point for concentration-response studies, benchmark experiments, and orthogonal validation. In comparative workflows, documenting the provided sequence cue (Ac-KPSSPPEE-NH2) can support traceability in comparative studies. This is particularly helpful for comparative experiments, benchmark studies, and orthogonal validation in which small differences in formulation or handling can complicate interpretation. For peptide-centered workflows, conclusions are usually strongest when biological readouts are paired with consistent preparation and appropriately matched reference conditions.